/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

L

Laura Richert

Université de Bordeaux(FR)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

192

Papers

3.3K

Citations

32

h-index

73

i10-index

Laura Richert is an academic researcher from Université de Bordeaux. The author has contributed to research in topics: HIV Research and Treatment & HIV/AIDS drug development and treatment & Viral Infections and Outbreaks Research. The author has an h-index of 32, co-authored 164 publications.

ORCID: 0000-0002-7682-2225

Research Topics

HIV Research and Treatment HIV/AIDS drug development and treatment Viral Infections and Outbreaks Research Immune Cell Function and Interaction HIV-related health complications and treatments

Papers by this author

works

Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV

2017 · Cell Reports · 124 citations

https://doi.org/10.1016/j.celrep.2017.08.023

Anne Rechtien Laura Richert Hadrien Lorenzo Glòria Martrus

A framework for the definition and interpretation of the use of surrogate endpoints in interventional trials

2023 · EClinicalMedicine · 49 citations

https://doi.org/10.1016/j.eclinm.2023.102283

Oriana Ciani Anthony Muchai Manyara Philippa Davies Derek Stewart

Reporting of surrogate endpoints in randomised controlled trial reports (CONSORT-Surrogate): extension checklist with explanation and elaboration

2024 · BMJ · 43 citations

https://doi.org/10.1136/bmj-2023-078524

Anthony Muchai Manyara Philippa Davies Derek Stewart Christopher J. Weir

Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial)

2020 · Trials · 32 citations

https://doi.org/10.1186/s13063-020-04619-1

Alexandre Duvignaud Édouard Lhomme Thierry Pistone Racha Onaisi

Inducible Bronchus-Associated Lymphoid Tissue (iBALT) Synergizes with Local Lymph Nodes during Antiviral CD4 <sup>+</sup> T Cell Responses

2013 · Lymphatic Research and Biology · 29 citations

https://doi.org/10.1089/lrb.2013.0015

Laura Richert Ann Harmsen Ann Harmsen Agnieszka Rynda‐Apple

Durable natural killer cell responses after heterologous two-dose Ebola vaccination

2021 · npj Vaccines · 19 citations

https://doi.org/10.1038/s41541-021-00280-0

Helen R. Wagstaffe Giada Susannini Rodolphe Thiébaut Laura Richert

Research topics

topics

HIV Research and Treatment

HIV/AIDS drug development and treatment

Viral Infections and Outbreaks Research

Immune Cell Function and Interaction

HIV-related health complications and treatments

Chat about Author

Papers

Chat

Click to start Chat